Publicaciones

2023

Epitranscriptomics: new players in an old game.

Coego A, Covelo-Molares H, Guallar D.

Biochemical Society Transactions (2023) 0 1 -14.

Exploring the Effect of Halogenation in a Series of Potent and Selective A2B Adenosine Receptor Antagonists.

Prieto-Díaz R, González-Gómez M, Fojo-Carballo H, Azuaje J, El Maatougui A, Majellaro M, Loza MI, Brea J, Fernández-Dueñas V, Paleo MR, Díaz-Holguín A, Garcia-Pinel B, Mallo-Abreu A, Estévez JC, Andújar-Arias A, García-Mera X, Gomez-Tourino I, Ciruela F, Salas CO, Gutiérrez-de-Terán H, Sotelo E.

J Med Chem. 2023 Jan 12;66(1):890-912.

Immunity and Small Molecules, Pharmacology Applied to Drug Discovery

Fezolinetant for menopausal hot flashes and night sweats.

González-García I, López M

Trends in Pharmacological Sciences (2023) 7:S0165-6147(23)00130-X.

NeurObesity, Neuroendocrine Regulation of Metabolism

MSIMEP: Predicting microsatellite instability from microarray DNA methylation tumor profiles

iScience Volume 26, Issue 3, 106127, March 17, 2023

Mobile Genomes

Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds-synthesis, biological activity, and structural evaluation.

Stępnicki P, Wronikowska-Denysiuk O, Zięba A, Targowska-Duda KM, Bartyzel A, Wróbel MZ, Wróbel TM, Szałaj K, Chodkowski A, Mirecka K, Budzyńska B, Fornal E, Turło J, Castro M, Kaczor AA.

J Enzyme Inhib Med Chem. 2023 Dec;38(1):2209828.

Molecular Pharmacology of G protein-coupled receptors